131 related articles for article (PubMed ID: 31786940)
1. [Retrospective examination of the Hungarian breast and cervical cancer screening programmes according to mortality and morbidity data].
Sárváry A; Bálint PC; Gyulai A; Kósa Z
Orv Hetil; 2019 Dec; 160(49):1948-1956. PubMed ID: 31786940
[TBL] [Abstract][Full Text] [Related]
2. Nationwide screening program for breast and cervical cancers in Hungary: special challenges, outcomes, and the role of the primary care provider.
Kolozsvári LR; Langmár Z; Rurik I
Eur J Gynaecol Oncol; 2013; 34(5):419-24. PubMed ID: 24475575
[TBL] [Abstract][Full Text] [Related]
3. [Cervical cancer incidence and mortality rates including the screening program results in the Podkarpackie Region between 1999-2010].
Karczmarek-Borowska B; Grsdalska-Lampart M
Ginekol Pol; 2013 Nov; 84(11):930-7. PubMed ID: 24455849
[TBL] [Abstract][Full Text] [Related]
4. [Attendance of the fourth (2008-2009) screening round of the Hungarian organized, nationwide breast cancer screening program].
Boncz I; Döbrőssy L; Péntek Z; Kovács A; Budai A; Imre L; Vajda R; Sebestyén A
Orv Hetil; 2013 Dec; 154(50):1975-83. PubMed ID: 24317356
[TBL] [Abstract][Full Text] [Related]
5. Breast and cervical cancer screening programme implementation in 16 countries.
Dowling EC; Klabunde C; Patnick J; Ballard-Barbash R;
J Med Screen; 2010; 17(3):139-46. PubMed ID: 20956724
[TBL] [Abstract][Full Text] [Related]
6. Social disparities in access to breast and cervical cancer screening by women living in Spain.
Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López de Andrés A
Public Health; 2015 Jul; 129(7):881-8. PubMed ID: 25818014
[TBL] [Abstract][Full Text] [Related]
7. [Responsible cancer screening].
Verbeek AL; van Dijck JA; Kiemeney LA; Broeders MJ
Ned Tijdschr Geneeskd; 2011; 155(45):A3934. PubMed ID: 22085573
[TBL] [Abstract][Full Text] [Related]
8. [Participation rates in the third round (2006-2007) of the breast cancer screening program in Hungary].
Boncz I; Döbrõssy L; Péntek Z; Kovács A; Budai A; Vajda R; Sebestyén A
Magy Onkol; 2013 Sep; 57(3):140-6. PubMed ID: 24107819
[TBL] [Abstract][Full Text] [Related]
9. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
[No Abstract] [Full Text] [Related]
10. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
11. [The coverage of cervical screening in Hungary].
Boncz I; Sebestyén A; Döbrossy L; Kovács A; Budai A; Székely T
Orv Hetil; 2007 Nov; 148(46):2177-82. PubMed ID: 17988975
[TBL] [Abstract][Full Text] [Related]
12. General practitioners can increase participation in cervical cancer screening - a model program in Hungary.
Gyulai A; Nagy A; Pataki V; Tonté D; Ádány R; Vokó Z
BMC Fam Pract; 2018 May; 19(1):67. PubMed ID: 29778099
[TBL] [Abstract][Full Text] [Related]
13. The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England.
Simonella L; Canfell K
Cancer Causes Control; 2013 Sep; 24(9):1727-36. PubMed ID: 23832659
[TBL] [Abstract][Full Text] [Related]
14. [Screening for cervical and breast cancer].
Wilm J; Schüler-Toprak S; Ortmann O
Pathologe; 2016 Sep; 37(5):477-89. PubMed ID: 27577734
[TBL] [Abstract][Full Text] [Related]
15. Are cervical and breast cancer screening programmes equitable? The case of women with intellectual and developmental disabilities.
Cobigo V; Ouellette-Kuntz H; Balogh R; Leung F; Lin E; Lunsky Y
J Intellect Disabil Res; 2013 May; 57(5):478-88. PubMed ID: 23506206
[TBL] [Abstract][Full Text] [Related]
16. Nonbreast cancer incidence, treatment received and outcomes: Are there differences in breast screening attendees versus nonattendees?
Walpole E; Dunn N; Youl P; Harden H; Furnival C; Moore J; Taylor K; Evans E; Philpot S
Int J Cancer; 2020 Aug; 147(3):856-865. PubMed ID: 31808149
[TBL] [Abstract][Full Text] [Related]
17. Breast and cervical cancer screening in Spain and predictors of adherence.
Martín-López R; Hernández-Barrera V; De Andres AL; Garrido PC; De Miguel AG; García RJ
Eur J Cancer Prev; 2010 May; 19(3):239-45. PubMed ID: 20110817
[TBL] [Abstract][Full Text] [Related]
18. Breast and Cervical Cancer Screening in Palau: Have We Improved Early Detection and Survival?
Tutii IM; Roseveare C; Viney K; Cash HL; Udui T; Ikerdeu E
Hawaii J Med Public Health; 2017 Dec; 76(12):337-343. PubMed ID: 29242759
[TBL] [Abstract][Full Text] [Related]
19. Barriers to Organized Mammography Screening Programs in Hungary: A Questionnaire-based Study of 3,313 Women.
Újhelyi M; Pukancsik D; Kelemen P; Kovács E; Kenessey I; Bak M; Kásler M; Kovács T; Mátrai Z
Anticancer Res; 2018 Mar; 38(3):1727-1734. PubMed ID: 29491109
[TBL] [Abstract][Full Text] [Related]
20. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
Lawson HW; Henson R; Bobo JK; Kaeser MK
MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
